Ziccum AB (publ) (ZICC.ST)

SEK 0.35

(-9.07%)

Eps Summary of Ziccum AB (publ)

  • Ziccum AB (publ)'s latest annual eps in 2023 was -1.54 SEK , up 24.88% from previous year.
  • Ziccum AB (publ)'s latest quarterly eps in 2024 Q2 was -0.52 SEK , down -92.59% from previous quarter.
  • Ziccum AB (publ) reported an annual eps of -2.05 SEK in 2022, down -7.33% from previous year.
  • Ziccum AB (publ) reported an annual eps of -1.91 SEK in 2021, up 6.83% from previous year.
  • Ziccum AB (publ) reported a quarterly eps of -0.27 SEK for 2024 Q1, up 50.91% from previous quarter.
  • Ziccum AB (publ) reported a quarterly eps of -0.52 SEK for 2024 Q2, down -92.59% from previous quarter.

Annual Eps Chart of Ziccum AB (publ) (2023 - 2017)

Historical Annual Eps of Ziccum AB (publ) (2023 - 2017)

Year Eps Eps Growth
2023 -1.54 SEK 24.88%
2022 -2.05 SEK -7.33%
2021 -1.91 SEK 6.83%
2020 -2.05 SEK -41.38%
2019 -1.45 SEK -14.17%
2018 -1.27 SEK -568.42%
2017 -0.19 SEK 0.0%

Peer Eps Comparison of Ziccum AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK -180.0%
Modus Therapeutics Holding AB (publ) -1.01 SEK -52.475%
BioArctic AB (publ) 2.60 SEK 159.231%
Sprint Bioscience AB (publ) -0.01 SEK -24344.444%
Mendus AB (publ) -4.40 SEK 65.0%
Genovis AB (publ.) 0.94 SEK 263.83%
Intervacc AB (publ) -1.69 SEK 8.876%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -600.0%
Active Biotech AB (publ) -0.17 SEK -805.882%
Magle Chemoswed Holding AB (publ) 1.13 SEK 236.283%
Bio-Works Technologies AB (publ) -1.57 SEK 1.911%
Aptahem AB (publ) -0.05 SEK -3088.406%
Vicore Pharma Holding AB (publ) -3.22 SEK 52.174%
Kancera AB (publ) -0.80 SEK -92.5%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 84.523%
Fluicell AB (publ) -0.24 SEK -541.667%
Saniona AB (publ) -1.29 SEK -19.38%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -710.526%
Biovica International AB (publ) -2.14 SEK 28.037%
Spago Nanomedical AB (publ) -0.43 SEK -258.14%
AcouSort AB (publ) -1.29 SEK -19.38%
Xintela AB (publ) -0.13 SEK -1084.615%
Abliva AB (publ) -0.09 SEK -1603.54%
Egetis Therapeutics AB (publ) -1.27 SEK -21.26%
Karolinska Development AB (publ) 0.02 SEK 7800.0%
OncoZenge AB (publ) -1.36 SEK -13.235%
Amniotics AB (publ) -0.01 SEK -13900.0%
2cureX AB (publ) -1.85 SEK 16.757%
CombiGene AB (publ) -1.80 SEK 14.444%
Asarina Pharma AB (publ) -0.57 SEK -170.175%
Calliditas Therapeutics AB (publ) -8.69 SEK 82.278%
Camurus AB (publ) 7.78 SEK 119.794%
Corline Biomedical AB -0.08 SEK -1728.979%
IRLAB Therapeutics AB (publ) -3.43 SEK 55.102%
Isofol Medical AB (publ) -0.23 SEK -569.565%
I-Tech AB 1.70 SEK 190.588%
Hansa Biopharma AB (publ) -15.83 SEK 90.272%
Cyxone AB (publ) -0.22 SEK -600.0%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 22.222%
Biosergen AB -0.60 SEK -156.667%
Cantargia AB (publ) -1.65 SEK 6.667%
NextCell Pharma AB -1.03 SEK -49.515%
Xspray Pharma AB (publ) -6.76 SEK 77.219%
Elicera Therapeutics AB (publ) -0.83 SEK -85.542%
Nanologica AB (publ) -2.05 SEK 24.878%
SynAct Pharma AB -6.64 SEK 76.807%
Annexin Pharmaceuticals AB (publ) -0.26 SEK -492.308%
Stayble Therapeutics AB (publ) -0.92 SEK -67.391%
LIDDS AB (publ) -0.63 SEK -144.444%
Lipum AB (publ) -4.45 SEK 65.393%
BioInvent International AB (publ) -5.02 SEK 69.323%
Alzinova AB (publ) -0.41 SEK -275.61%
Oncopeptides AB (publ) -1.96 SEK 21.429%
Pila Pharma AB (publ) -0.47 SEK -227.66%
Guard Therapeutics International AB (publ) -11.26 SEK 86.323%
Scandinavian ChemoTech AB (publ) -1.13 SEK -36.283%
Simris Alg AB (publ) -0.16 SEK -862.5%
Diamyd Medical AB (publ) -1.60 SEK 3.75%
Xbrane Biopharma AB (publ) -1.27 SEK -21.26%
Ascelia Pharma AB (publ) -3.24 SEK 52.469%
Diagonal Bio AB (publ) -0.32 SEK -381.25%